1α,25-Dihydroxyvitamin D3 Promotes Angiogenesis After Cerebral Ischemia Injury in Rats by Upregulating the TGF-β/Smad2/3 Signaling Pathway.
1α
25-dihydroxyvitamin D3
TGF-β/Smad2/3 signaling pathway
angiogenesis
cerebral ischemia-reperfusion
vascular endothelial growth factor
vitamin D receptor
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2022
2022
Historique:
received:
02
09
2021
accepted:
21
02
2022
entrez:
4
4
2022
pubmed:
5
4
2022
medline:
5
4
2022
Statut:
epublish
Résumé
Stroke is a disease with high morbidity, disability and mortality, which seriously endangers the life span and quality of life of people worldwide. Angiogenesis and neuroprotection are the key to the functional recovery of penumbra function after acute cerebral infarction. In this study, we used the middle cerebral artery occlusion (MCAO) model to investigate the effects of 1α,25-dihydroxyvitamin D3 (1,25-D3) on transforming growth factor-β (TGF-β)/Smad2/3 signaling pathway. Cerebral infarct volume was measured by TTC staining. A laser speckle flow imaging system was used to measure cerebral blood flow (CBF) around the ischemic cortex of the infarction, followed by platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) and isolectin-B4 (IB4) immunofluorescence. The expression of vitamin D receptor (VDR), TGF-β, Smad2/3, p-Smad2, p-Smad3, and vascular endothelial growth factor (VEGF) was analyzed by western blot and RT-qPCR. Results showed that compared with the sham group, the cerebral infarction volume was significantly increased while the CBF was reduced remarkably in the MCAO group. 1,25-D3 reduced cerebral infarction volume, increased the recovery of CBF and expressions of VDR, TGF-β, p-Smad2, p-Smad3, and VEGF, significantly increased IB4
Identifiants
pubmed: 35369317
doi: 10.3389/fcvm.2022.769717
pmc: PMC8966232
doi:
Types de publication
Journal Article
Langues
eng
Pagination
769717Informations de copyright
Copyright © 2022 Zhang, Mu, Ding, Du, Zhou, Li, Gong, Zhang, Geng and Wang.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
BMB Rep. 2020 Nov;53(11):600-604
pubmed: 33050988
Neuroimmunomodulation. 2020;27(4):178-185
pubmed: 33601398
J Neuroimmune Pharmacol. 2020 Jun;15(2):280-291
pubmed: 31863333
Endocrinology. 2020 Nov 1;161(11):
pubmed: 32987399
Stroke. 1989 Jan;20(1):84-91
pubmed: 2643202
Circ Res. 2016 Jan 22;118(2):230-40
pubmed: 26596284
Ann Rheum Dis. 2018 Mar;77(3):431-440
pubmed: 29259049
Stroke. 1997 Oct;28(10):2039-44
pubmed: 9341716
J Exp Med. 2008 Feb 18;205(2):491-501
pubmed: 18268040
Neurochem Res. 2019 Nov;44(11):2606-2618
pubmed: 31555994
Cells. 2020 Apr 26;9(5):
pubmed: 32357544
PLoS One. 2018 Aug 20;13(8):e0201395
pubmed: 30125282
Exp Mol Med. 2020 Mar;52(3):450-460
pubmed: 32152452
Stroke. 2012 Sep;43(9):2430-6
pubmed: 22811460
Inflammopharmacology. 2021 Feb;29(1):153-166
pubmed: 33201349
Biomedicines. 2020 Jul 31;8(8):
pubmed: 32752069
Best Pract Res Clin Endocrinol Metab. 2011 Aug;25(4):543-59
pubmed: 21872797
J Reprod Immunol. 2021 Jun;145:103311
pubmed: 33812317
Eur J Med Chem. 2020 Dec 1;207:112738
pubmed: 32829183
Mol Med Rep. 2017 Apr;15(4):2273-2279
pubmed: 28259913
Vasc Cell. 2013 Feb 06;5(1):3
pubmed: 23388410
FASEB Bioadv. 2019 Jul;1(7):415-434
pubmed: 31396585
J Cereb Blood Flow Metab. 2021 Apr;41(4):857-873
pubmed: 33736511
Stroke. 2021 Jan;52(2):729-734
pubmed: 33467874
Eur Rev Med Pharmacol Sci. 2019 Nov;23(21):9633-9641
pubmed: 31773714
N Engl J Med. 2018 Aug 16;379(7):611-622
pubmed: 29766770
Front Cell Neurosci. 2018 Dec 17;12:480
pubmed: 30618630
Mol Immunol. 2017 Nov;91:156-164
pubmed: 28926770
J Cereb Blood Flow Metab. 2019 May;39(5):753-769
pubmed: 30841779
Int J Mol Sci. 2020 Dec 31;22(1):
pubmed: 33396382
Biochem Biophys Res Commun. 2019 Aug 13;516(1):75-81
pubmed: 31196627
Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):7086-91
pubmed: 9618543
J Cell Physiol. 2019 Jun;234(6):8834-8845
pubmed: 30317638
Med Sci Monit. 2017 Jan 22;23:366-376
pubmed: 28110342
PLoS One. 2015 Mar 27;10(3):e0122821
pubmed: 25815722
Int J Nanomedicine. 2019 Oct 07;14:8013-8031
pubmed: 31632015
Eur J Neurol. 2013 Jan;20(1):57-61
pubmed: 22632854
J Alzheimers Dis. 2014;42(3):789-99
pubmed: 24934545
Circ Res. 2017 Feb 3;120(3):541-558
pubmed: 28154103
Int J Mol Sci. 2021 Apr 11;22(8):
pubmed: 33920472
Anticancer Res. 2014 Jun;34(6):2735-43
pubmed: 24922634